AKT1 and breast carcinoma: However, GDC-0084 and GDC-0068 have demonstrated the capacity to overcome this hurdle by inhibiting the PI3K-Akt-mTOR pathway and exhibiting potential to treat breast cancer brain metastasis.303,304